HROW
$28.07+1.41%
HROW — Harrow Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
5.010.015.020.025.030.035.040.045.050.055.0010.0M20.0M$28.07—20162019202120242026
2026-10-20
Price$28.07
MA20$36.47
MA50$39.78
Vol2.2M
Key stats#
Price data
- Price
- $28.07
- YTD price return
- -42.71%
- YTD total return
- -42.71%
- Next earnings
- Nov 9, 2026
- Market cap
- 1.1B
- Enterprise value
- 1.3B
- Shares outstanding
- 37.5M
- 52W low
- $26.96
- 52W high
- $54.85
- From 52W high
- -48.82%
- From 52W low
- +4.12%
- 52W range
- 4%
Volume
- Rel volume
- 0.83×
- 30D volume
- 628.7K
- 30D $ vol
- 19.8M
Fundamentals
- Sales (ttm)
- 275.6M
- Sales/share
- $7.35
- EPS (ttm)
- -$0.99
- FCF (ttm)
- 5M
- FCF/share
- $0.13
- Book value/share
- $0.41
- Net margin
- -13.51%
- ROE
- -244.91%
- ROA
- -8.93%
- Debt / equity
- 19.74×
- Current ratio
- 2.24
Growth (CAGR, ttm) · 10Y
- Sales
- +21.07%+38.94%+34.52%+33.38%
- FCF
- +97.42%n/a-11.16%n/a
- Shares
- +1.31%+2.20%+6.87%+11.02%
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +19.50%+35.95%+25.88%+20.14%
- FCF/share
- +94.86%n/a-16.87%n/a
- Book value/share
- -69.81%-14.03%-14.02%-0.48%
- Price
- -33.39%+24.91%+22.81%+25.05%
- Total return
- -33.39%+24.91%+22.81%+25.05%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -28.4×
- P/OI (ttm)
- 78.0×
- Fwd P/E
- 10.3×
- P/S (ttm)
- 3.8×
- P/B (mrq)
- 69.2×
- P/FCF (ttm)
- 209.8×
- EV/EBITDA (fy)
- 40.1×
- EV/Sales (ttm)
- 4.6×
- FCF yield (ttm)
- 0.48%
- Buyback yield (realized, 1y)
- -1.31%
- Shareholder yield (realized, 1y)
- -1.31%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/OI
- 33rd
- P/S
- 56th
- P/B
- 92nd
- P/FCF
- 65th
Bar = where today’s multiple sits in HROW’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-20#
1D
+1.41%
5D
-0.60%
1M
-15.15%
3M
-36.85%
YTD
-42.71%
1Y
-33.37%
5Y
+179.30%
Financial statements
Open full HROW financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
